VOAM
BOLD

Vertex One Asset Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Vertex One Asset Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$6.88M Buy
+115,000
New +$4.32M 1.58% 15

Other funds holding BOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vertex One Asset Management's BOLD Position: Q4 2019 in Review

Vertex One Asset Management opened a new position in Audentes Therapeutics, Inc (BOLD) in Q4 2019: 115,000 shares worth $6.88M. The stake represents 1.58% of the portfolio and ranks #15 among its holdings.

188 funds tracked by Wall St. Rank hold BOLD as of Q4 2019.

  • Vertex One Asset Management held 115,000 shares of Audentes Therapeutics, Inc worth $6.88M as of Q4 2019.
  • Audentes Therapeutics, Inc was a new Vertex One Asset Management position in Q4 2019.
  • Audentes Therapeutics, Inc made up 1.58% of Vertex One Asset Management's portfolio in Q4 2019, its #15 holding.
  • 188 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q4 2019.

Based on Vertex One Asset Management's 13F filing for Q4 2019, filed 21 Jan 2020.